174 related articles for article (PubMed ID: 38206116)
1. Investigational thymic stromal lymphopoietin inhibitors for the treatment of asthma: a systematic review.
Rogliani P; Manzetti GM; Bettin FR; D'Auria M; Calzetta L
Expert Opin Investig Drugs; 2024 Jan; 33(1):39-49. PubMed ID: 38206116
[TBL] [Abstract][Full Text] [Related]
2. Development of an inhaled anti-TSLP therapy for asthma.
O'Byrne PM; Panettieri RA; Taube C; Brindicci C; Fleming M; Altman P
Pulm Pharmacol Ther; 2023 Feb; 78():102184. PubMed ID: 36535465
[TBL] [Abstract][Full Text] [Related]
3. Tezepelumab: a novel biological therapy for the treatment of severe uncontrolled asthma.
Marone G; Spadaro G; Braile M; Poto R; Criscuolo G; Pahima H; Loffredo S; Levi-Schaffer F; Varricchi G
Expert Opin Investig Drugs; 2019 Nov; 28(11):931-940. PubMed ID: 31549891
[No Abstract] [Full Text] [Related]
4. Unmet need in severe, uncontrolled asthma: can anti-TSLP therapy with tezepelumab provide a valuable new treatment option?
Menzies-Gow A; Wechsler ME; Brightling CE
Respir Res; 2020 Oct; 21(1):268. PubMed ID: 33059715
[TBL] [Abstract][Full Text] [Related]
5. Tezepelumab: an anti-thymic stromal lymphopoietin monoclonal antibody for the treatment of asthma.
Shinkai M; Yabuta T
Immunotherapy; 2023 Dec; 15(17):1435-1447. PubMed ID: 37724378
[TBL] [Abstract][Full Text] [Related]
6. Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma.
Gauvreau GM; Sehmi R; Ambrose CS; Griffiths JM
Expert Opin Ther Targets; 2020 Aug; 24(8):777-792. PubMed ID: 32567399
[TBL] [Abstract][Full Text] [Related]
7. Thymic Stromal Lymphopoietin and Tezepelumab in Airway Diseases: From Physiological Role to Target Therapy.
Bagnasco D; De Ferrari L; Bondi B; Candeliere MG; Mincarini M; Riccio AM; Braido F
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892164
[TBL] [Abstract][Full Text] [Related]
8. Thymic stromal lymphopoietin receptor blockade reduces allergic inflammation in a cynomolgus monkey model of asthma.
Cheng DT; Ma C; Niewoehner J; Dahl M; Tsai A; Zhang J; Gonsiorek W; Apparsundaram S; Pashine A; Ravindran P; Jung J; Hang J; Allard J; Bitter H; Tribouley C; Narula S; Wilson S; Fuentes ME
J Allergy Clin Immunol; 2013 Aug; 132(2):455-62. PubMed ID: 23810153
[TBL] [Abstract][Full Text] [Related]
9. Current summary of clinical studies on anti-TSLP antibody, Tezepelumab, in asthma.
Kurihara M; Kabata H; Irie M; Fukunaga K
Allergol Int; 2023 Jan; 72(1):24-30. PubMed ID: 36470789
[TBL] [Abstract][Full Text] [Related]
10. Tezepelumab for asthma.
Nolasco S; Pelaia C; Scioscia G; Campisi R; Crimi C
Drugs Today (Barc); 2022 Dec; 58(12):591-603. PubMed ID: 36651067
[TBL] [Abstract][Full Text] [Related]
11. Anti-TSLP antibodies: Targeting a master regulator of type 2 immune responses.
Nakajima S; Kabata H; Kabashima K; Asano K
Allergol Int; 2020 Apr; 69(2):197-203. PubMed ID: 31974038
[TBL] [Abstract][Full Text] [Related]
12. Expression and Regulation of Thymic Stromal Lymphopoietin and Thymic Stromal Lymphopoietin Receptor Heterocomplex in the Innate-Adaptive Immunity of Pediatric Asthma.
Lin SC; Cheng FY; Liu JJ; Ye YL
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29670037
[TBL] [Abstract][Full Text] [Related]
13. Thymic stromal lymphopoietin: a central regulator of allergic asthma.
Watson B; Gauvreau GM
Expert Opin Ther Targets; 2014 Jul; 18(7):771-85. PubMed ID: 24930783
[TBL] [Abstract][Full Text] [Related]
14. Thymic stromal lymphopoietin (TSLP) and Toluene-diisocyanate-induced airway inflammation: Alleviation by TSLP neutralizing antibody.
Yu G; Zhang Y; Wang X; Sai L; Bo C; Yeo AJ; Lavin MF; Peng C; Jia Q; Shao H
Toxicol Lett; 2019 Dec; 317():59-67. PubMed ID: 31577921
[TBL] [Abstract][Full Text] [Related]
15. Positioning of Tezepelumab in Severe Asthma.
Miralles-López JC; Antolín-Amérigo D; García-Moguel I; Domínguez-Ortega J; Delgado-Romero J; Quirce S
J Investig Allergol Clin Immunol; 2024 Feb; 34(1):1-11. PubMed ID: 37812191
[TBL] [Abstract][Full Text] [Related]
16. Thymic Stromal Lymphopoietin (TSLP), Its Isoforms and the Interplay with the Epithelium in Allergy and Asthma.
Smolinska S; Antolín-Amérigo D; Popescu FD; Jutel M
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628907
[TBL] [Abstract][Full Text] [Related]
17. Thymic stromal lymphopoietin plays divergent roles in murine models of atopic and nonatopic airway inflammation.
Yadava K; Massacand J; Mosconi I; Nicod LP; Harris NL; Marsland BJ
Allergy; 2014 Oct; 69(10):1333-42. PubMed ID: 24961817
[TBL] [Abstract][Full Text] [Related]
18. Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma.
Gauvreau GM; Hohlfeld JM; FitzGerald JM; Boulet LP; Cockcroft DW; Davis BE; Korn S; Kornmann O; Leigh R; Mayers I; Watz H; Grant SS; Jain M; Cabanski M; Pertel PE; Jones I; Lecot JR; Cao H; O'Byrne PM
Eur Respir J; 2023 Mar; 61(3):. PubMed ID: 36822634
[TBL] [Abstract][Full Text] [Related]
19. Severe Asthmatic Responses: The Impact of TSLP.
Theofani E; Tsitsopoulou A; Morianos I; Semitekolou M
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108740
[TBL] [Abstract][Full Text] [Related]
20. TSLP Inhibitors for Asthma: Current Status and Future Prospects.
Matera MG; Rogliani P; Calzetta L; Cazzola M
Drugs; 2020 Apr; 80(5):449-458. PubMed ID: 32078149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
